Literature DB >> 2052718

Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging.

O Clement1, G Frija, C Chambon, E Schouman-Clayes, J F Mosnier, M F Poupon, B Balkau.   

Abstract

The influence of cirrhosis on superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance (MR) imaging of the liver was studied in 31 rats. Experimental models included carbon tetrachloride-induced cirrhosis and liver engrafting of rhabdomyosarcoma S4T cells. Hepatic uptake of SPIO measured with relaxometry decreased dramatically with histologic grade, while splenic uptake increased; the same results were achieved by calculating K values. Imaging of 13 tumorous cirrhotic rats confirmed these results by showing a muted decrease in liver signal intensity on spin-echo images after injection of SPIO. Nevertheless, all intrahepatic tumors could be visualized, as confirmed by postmortem examination. On gradient-echo images, postinjection contrast between the tumor and the liver was not affected by cirrhosis. Thus, despite strong impairment of hepatic uptake in cirrhosis, the diagnostic efficacy of MR imaging with SPIO did not seem to be significantly affected.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052718     DOI: 10.1148/radiology.180.1.2052718

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  7 in total

1.  Correlation of Kupffer cell function and hepatocyte function in chronic viral hepatitis evaluated with superparamagnetic iron oxide-enhanced magnetic resonance imaging and scintigraphy using technetium-99m-labelled galactosyl human serum albumin.

Authors:  Tatsuyuki Tonan; Kiminori Fujimoto; Aliya Qayyum; Sanae Azuma; Masatoshi Ishibashi; Takato Ueno; Noriyuki Ono; Junji Akiyoshi; Sunao Matsushita; Naofumi Hayabuchi; Takumi Kawaguchi; Michio Sata
Journal:  Exp Ther Med       Date:  2011-04-11       Impact factor: 2.447

2.  Characterization of focal hepatic lesions with SPIO-enhanced MRI.

Authors:  Wei-Wei Zheng; Kang-Rong Zhou; Zu-Wang Chen; Ji-Zhang Shen; Cai-Zhong Chen; Shu-Jie Zhang
Journal:  World J Gastroenterol       Date:  2002-02       Impact factor: 5.742

3.  MR characterisation of dysplastic nodules and hepatocarcinoma in the cirrhotic liver with hepatospecific superparamagnetic contrast agents: pathological correlation in explanted livers.

Authors:  L Macarini; P Milillo; A Cascavilla; G Scalzo; L Stoppino; R Vinci; G Moretti; G Ettorre
Journal:  Radiol Med       Date:  2009-11-09       Impact factor: 3.469

4.  Detection of hepatocellular carcinoma: comparison of ferumoxides-enhanced and gadolinium-enhanced dynamic three-dimensional volume interpolated breath-hold MR imaging.

Authors:  Hyo-Sung Kwak; Jeong-Min Lee; Young-Kon Kim; Young Hwan Lee; Chong-Soo Kim
Journal:  Eur Radiol       Date:  2004-09-22       Impact factor: 5.315

5.  MDCT and superparamagnetic iron oxide (SPIO)-enhanced MR findings of intrapancreatic accessory spleen in seven patients.

Authors:  Se Hyung Kim; Jeong Min Lee; Joon Koo Han; Jae Young Lee; Won Joon Kang; Jin Young Jang; Kyung-Sook Shin; Kyunghee C Cho; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2006-03-18       Impact factor: 5.315

Review 6.  Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media.

Authors:  Carlo Bartolozzi; Laura Crocetti; Riccardo Lencioni; Dania Cioni; Clotilde Della Pina; Daniela Campani
Journal:  Eur Radiol       Date:  2007-02-16       Impact factor: 7.034

7.  Monoclonal antibody A7-superparamagnetic iron oxide as contrast agent of MR imaging of rectal carcinoma.

Authors:  A Toma; E Otsuji; Y Kuriu; K Okamoto; D Ichikawa; A Hagiwara; H Ito; T Nishimura; H Yamagishi
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.